Seagen, A Wholly Owned Subsidiary Of Pfizer

This study tested whether combining two drugs, brentuximab vedotin and pembrolizumab, can shrink tumors in people with advanced melanoma, lung cancer, or head and neck cancer that has spread. The trial included 161 participants and measured how many saw their tumors shrink. It al…